BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25872549)

  • 1. Suspected side effects to the quadrivalent human papilloma vaccine.
    Brinth L; Theibel AC; Pors K; Mehlsen J
    Dan Med J; 2015 Apr; 62(4):A5064. PubMed ID: 25872549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015.
    Vichnin M; Bonanni P; Klein NP; Garland SM; Block SL; Kjaer SK; Sings HL; Perez G; Haupt RM; Saah AJ; Lievano F; Velicer C; Drury R; Kuter BJ
    Pediatr Infect Dis J; 2015 Sep; 34(9):983-91. PubMed ID: 26107345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthostatic intolerance and postural tachycardia syndrome as suspected adverse effects of vaccination against human papilloma virus.
    Brinth LS; Pors K; Theibel AC; Mehlsen J
    Vaccine; 2015 May; 33(22):2602-5. PubMed ID: 25882168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gardasil Vaccination for Recurrent Laryngeal Papillomatosis in Adult Men: First Report: Changes in HPV Antibody Titer.
    Makiyama K; Hirai R; Matsuzaki H
    J Voice; 2017 Jan; 31(1):104-106. PubMed ID: 27068425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events following Quadrivalent HPV vaccination reported in Sao Paulo State, Brazil, in the first three years after introducing the vaccine for routine immunization (March 2014 to December 2016).
    Mauro AB; Fernandes EG; Miyaji KT; Arantes BA; Valente MG; Sato HK; Sartori AMC
    Rev Inst Med Trop Sao Paulo; 2019 Sep; 61():e43. PubMed ID: 31531621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papilloma virus vaccination induces strong human papilloma virus specific cell-mediated immune responses in HIV-infected adolescents and young adults.
    Rainone V; Giacomet V; Penagini F; Fabiano V; Calascibetta F; Mameli C; Pisanelli S; Zuccotti GV; Clerici M; Trabattoni D
    AIDS; 2015 Mar; 29(6):739-43. PubMed ID: 25849837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States.
    Gee J; Weinbaum C; Sukumaran L; Markowitz LE
    Hum Vaccin Immunother; 2016 Jun; 12(6):1406-17. PubMed ID: 27029786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adverse reactions to human papillomavirus vaccine in the Valencian Community (2007-2011)].
    Rodríguez-Galán MA; Pérez-Vilar S; Díez-Domingo J; Tuells J; Gomar-Fayos J; Morales-Olivas F; Pastor-Villalba E
    An Pediatr (Barc); 2014 Nov; 81(5):303-9. PubMed ID: 24582127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between quadrivalent human papillomavirus vaccination and selected syndromes with autonomic dysfunction in Danish females: population based, self-controlled, case series analysis.
    Hviid A; Thorsen NM; Valentiner-Branth P; Frisch M; Mølbak K
    BMJ; 2020 Sep; 370():m2930. PubMed ID: 32878745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the risk of venous thromboembolism after quadrivalent human papillomavirus vaccination among US females.
    Yih WK; Greene SK; Zichittella L; Kulldorff M; Baker MA; de Jong JL; Gil-Prieto R; Griffin MR; Jin R; Lin ND; McMahill-Walraven CN; Reidy M; Selvam N; Selvan MS; Nguyen MD
    Vaccine; 2016 Jan; 34(1):172-8. PubMed ID: 26549364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative benefit-risk assessment by MCDA of the quadrivalent HPV vaccine for preventing anal cancer in males.
    Marcelon L; Verstraeten T; Dominiak-Felden G; Simondon F
    Expert Rev Vaccines; 2016; 15(1):139-48. PubMed ID: 26524376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of the quadrivalent human papillomavirus vaccine (gardasil) as adjuvant therapy in the treatment of recurrent respiratory papilloma.
    Young DL; Moore MM; Halstead LA
    J Voice; 2015 Mar; 29(2):223-9. PubMed ID: 25619468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case-control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events.
    Geier DA; Geier MR
    Clin Rheumatol; 2015 Jul; 34(7):1225-31. PubMed ID: 25535199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of venous thromboembolism risk following quadrivalent human papillomavirus vaccination, Vaccine Safety Datalink, 2008-2011.
    Naleway AL; Crane B; Smith N; Daley MF; Donahue J; Gee J; Greene SK; Harrington T; Jackson LA; Klein NP; Tseng HF; Vellozzi C; Weintraub ES;
    Vaccine; 2016 Jan; 34(1):167-71. PubMed ID: 26549361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unmasking in an observational vaccine safety study: Using type 2 diabetes mellitus as an example.
    Ackerson BK; Sy LS; Slezak J; Chao CR; Hechter RC; Takhar HS; Jacobsen SJ
    Vaccine; 2015 Nov; 33(46):6224-6. PubMed ID: 26440925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prophylactic role for the human papillomavirus quadrivalent vaccine in males.
    Yancey AM; Pitlick JM; Forinash AB
    Ann Pharmacother; 2010; 44(7-8):1314-8. PubMed ID: 20501891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Final report on exposure during pregnancy from a pregnancy registry for quadrivalent human papillomavirus vaccine.
    Goss MA; Lievano F; Buchanan KM; Seminack MM; Cunningham ML; Dana A
    Vaccine; 2015 Jun; 33(29):3422-8. PubMed ID: 25869893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine.
    Olsson SE; Villa LL; Costa RL; Petta CA; Andrade RP; Malm C; Iversen OE; Høye J; Steinwall M; Riis-Johannessen G; Andersson-Ellstrom A; Elfgren K; von Krogh G; Lehtinen M; Paavonen J; Tamms GM; Giacoletti K; Lupinacci L; Esser MT; Vuocolo SC; Saah AJ; Barr E
    Vaccine; 2007 Jun; 25(26):4931-9. PubMed ID: 17499406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bad news: The influence of news coverage and Google searches on Gardasil adverse event reporting.
    Faasse K; Porsius JT; Faasse J; Martin LR
    Vaccine; 2017 Dec; 35(49 Pt B):6872-6878. PubMed ID: 29128382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible adverse effects of the quadrivalent human papillomavirus vaccine in the Region of Southern Denmark: a retrospective, descriptive cohort study.
    Cramon C; Poulsen CL; Hartling UB; Holden IK; Johansen IS
    Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.